Psoriasis Clinical Trials

Showing 621-640 of 888 trials

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris

NCT01707043

This is an open label, investigator-blinded, cross over, prospective, single center study of subjects with plaque psoriasis. Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment and Taclonex Scalp® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension will each be applied topically once daily. The primary objective is to assess the patient preference for Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment compared to Taclonex Scalp® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension in the treatment of plaque psoriasis.

Plaque Psoriasis

Wake Forest University20 participantsStarted Oct 2012

Winston-Salem, North Carolina, United States

COMPLETEDPhase 3

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

NCT01901185

The purpose of this study is to assess the ability of people with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) to use an experimental autoinjector to self inject etanercept (Enbrel®).

Rheumatoid ArthritisPsoriatic Arthritis

Amgen77 participantsStarted Jun 2013

Huntsville, Alabama, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +10 more locations

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris

Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

Related Searches

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

Fertility Study of Women With Chronic Inflammatory Rheumatism

Ovarian Reserve in Patients With Psoriasis

Prevalence of Sleep Disturbances in Psoriasis

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Biologics Anchoring Study

Vascular Inflammation in Psoriasis - Extension Study

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis